ALR Technologies SG Ltd. (ALRTF)
ALR Technologies Inc. is a data management company dedicated to creating and providing diabetes care solutions for both human and animal health sectors across the United States. Central to its offerings is the comprehensive Diabetes Management System. This system facilitates data collection, provides predictive A1C analysis, offers recommendations for insulin dosage adjustments, tracks performance, enables remote patient monitoring, and supplies essential diabetes testing materials. The company also markets Continuous Glucose Monitoring (CGM) devices, which are wearable medical technologies designed to provide continuous blood sugar readings. Addressing a specific need in veterinary medicine, ALR Technologies offers the GluCurve Pet CGM, tailored for diabetic felines and canines, and utilized by veterinarians. Furthermore, their Prediabetes System supports patients with educational video content, supplementary resources optimized for mobile devices, and a private online community for discussing disease management strategies. ALR Technologies primarily serves healthcare providers, health insurance companies, and entities specializing in disease and case management services, including those within the home care industry. Originally incorporated in 1987 as Mo Betta Corp., the company rebranded to ALR Technologies Inc. in December 1998. It is based in Richmond, Virginia, and operates as a subsidiary of ALR Technologies SG Ltd.
Sector: Surgical & Medical Instruments & Apparatus
Industry: Medical - Devices
ALR Technologies Inc.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
based on 645.47M shares outstanding
USALR Technologies Inc. is a data management company dedicated to creating and providing diabetes care solutions for both human and animal health sectors across the United States. Central to its offerings is the comprehensive Diabetes Management System. This system facilitates data collection, provides predictive A1C analysis, offers recommendations for insulin dosage adjustments, tracks performance, enables remote patient monitoring, and supplies essential diabetes testing materials.
The company also markets Continuous Glucose Monitoring (CGM) devices, which are wearable medical technologies designed to provide continuous blood sugar readings. Addressing a specific need in veterinary medicine, ALR Technologies offers the GluCurve Pet CGM, tailored for diabetic felines and canines, and utilized by veterinarians. Furthermore, their Prediabetes System supports patients with educational video content, supplementary resources optimized for mobile devices, and a private online community for discussing disease management strategies. ALR Technologies primarily serves healthcare providers, health insurance companies, and entities specializing in disease and case management services, including those within the home care industry. Originally incorporated in 1987 as Mo Betta Corp., the company rebranded to ALR Technologies Inc. in December 1998.
It is based in Richmond, Virginia, and operates as a subsidiary of ALR Technologies SG Ltd.
Leadership
Sidney S. Chan
Chairman, Chief Executive Officer, President, Chief Financial Officer, Chief Accounting Officer & Treasurer
Christine Y. S. Kan
Vice President of Corporate Development & Director
Benjamin Szeto
Chief Legal Counsel, General Counsel & Secretary
Jacqueline Wu
Head of Corporation Marketing
Employees
7
Country
US
Sector
Healthcare
Website
alrt.com
| Name | Shares | % | Source |
|---|---|---|---|
 Kan Yuen Shan VP, Corporate, Director, 10% Owner | 193.7M | 30.0% | FORM 4 |
 Chan Sidney CEO, Director, 10% Owner | 189.8M | 29.4% | FORM 4 |
 Stafford Peter H Director | 1.4M | 0.2% | FORM 4 |
 Cheng Ronald Director | 1.2M | 0.2% | FORM 4 |
 Robulak Kenneth Director | 1.2M | 0.2% | FORM 4 |
Insiders
- Kan Yuen ShanVP, Corporate, Director, 10% Owner
- Chan SidneyCEO, Director, 10% Owner
- Stafford Peter HDirector
- Cheng RonaldDirector
- Robulak KennethDirector
based on 645.47M shares outstanding
US30d Avg
49.99K
60d Avg
41.13K
90d Avg
44.16K